Gene expression profiles in two comparisons (42 human TNBC versus 21 controls (ctr1), and 42 human ER+HER2-BC versus 30 controls (ctr2)) were analyzed using three methods (UQ-pgQ2, DESeq2 and edgeR). This evidence concerns the gene ERBB2 and breast cancer.